Best for prediabetes
The best GLP‑1 medications for prediabetes in 2026
Elevated blood sugar not yet at diabetic levels, often pre-clinical T2D.
Most relevant drugs
Top-scored options for prediabetes
Each score is our overall rating from the clinical rubric (effectiveness, safety, evidence, value). The left rule is color-keyed to the molecule.
8.8
/ 10
Zepbound
Tirzepatide
Read the full review →
8.7
/ 10
Mounjaro
Tirzepatide
Read the full review →
8.7
/ 10
Wegovy
Semaglutide
Read the full review →
8.5
/ 10
Ozempic
Semaglutide
Read the full review →
Molecule key: Semaglutide Tirzepatide Oral Other GLP-1
Full ranking
Every GLP-1 we rank for prediabetes
- Top pick1Editor's Choice
FDA-approved tirzepatide for weight loss
- Highest reported weight loss of any approved GLP-1 (avg ~21% in SURMOUNT-1)
- Dual GIP + GLP-1 mechanism
- FDA-approved for OSA + obesity (2024)
FDA-approvedBrand-nameOnce-weekly injectionDual GIP / GLP-1Insurance eligible8.8/10Editorial scoreiEditorial score — our drug ranking, weighted for clinical outcome (effectiveness and safety lead). Telehealth services also carry a separate Service scorecard (shown on the services pages), so the same brand can show a different number there.See reviewTrue cost · maint.$549/mo · 10mg+$150 - 2Runner-up
Tirzepatide for type 2 diabetes
- Significant A1C reduction
- Substantial weight loss as side benefit
Off-label useOnce-weekly injectionDual GIP / GLP-1Insurance eligible8.7/10Editorial scoreiEditorial score — our drug ranking, weighted for clinical outcome (effectiveness and safety lead). Telehealth services also carry a separate Service scorecard (shown on the services pages), so the same brand can show a different number there.See reviewTrue cost · maint.$549/mo · 7.5mg+$150 - 3Best for editor's choice#1· Editor's ChoiceEditor's ChoiceBest for CV Risk
FDA-approved semaglutide for chronic weight management
- Average 15% weight loss in clinical trials (STEP 1)
- FDA-approved with extensive safety record
- Weekly dosing
FDA-approvedBrand-nameOnce-weekly injectionGLP-1 receptor agonistInsurance eligibleMost transparent pricing8.7/10Editorial scoreiEditorial score — our drug ranking, weighted for clinical outcome (effectiveness and safety lead). Telehealth services also carry a separate Service scorecard (shown on the services pages), so the same brand can show a different number there.See reviewTrue cost · maint.$499/mo · 2.4mg - 4
Semaglutide approved for type 2 diabetes
- Strong A1C reduction in T2D
- Often covered by insurance for diabetes indication
Off-label useOnce-weekly injectionGLP-1 receptor agonistInsurance eligible8.5/10Editorial scoreiEditorial score — our drug ranking, weighted for clinical outcome (effectiveness and safety lead). Telehealth services also carry a separate Service scorecard (shown on the services pages), so the same brand can show a different number there.See reviewTrue cost · maint.$499/mo · 1mg
Quick comparison
Verified Jul 17, 2026| # | Product | Active ingredient | Starting price | True cost · maint. | FDA status | Score | |
|---|---|---|---|---|---|---|---|
| 1 | Zepbound | Tirzepatide | $1349/mo | $549/mo · 10mg+$150 | approved | Top ·8.8 | View → |
| 2 | Mounjaro | Tirzepatide | $1349/mo | $549/mo · 7.5mg+$150 | off-label | 8.7 | View → |
| 3 | Wegovy Most transparent pricing | Semaglutide | $1349/mo | Best ·$499/mo · 2.4mg | approved | 8.7 | View → |
| 4 | Ozempic | Semaglutide | Best ·$997/mo | Best ·$499/mo · 1mg | off-label | 8.5 | View → |
Summary
Our recommendations for prediabetes
A short read of who wins for which kind of patient.
Recommendation labels are computed from each product’s editorial badges + scoring rubric. See methodology for the full rubric — page /best-glp1-for/prediabetes.
Evidence
What the trials show
STEP-1 follow-up data and Mounjaro Phase 2 prevention studies show 60-70% reduction in T2D incidence over 3 years in high-risk prediabetic patients. The effect persists after discontinuation in roughly half of patients, suggesting durable metabolic reset.
Prescribing
How prescribers handle it
Currently off-label for prediabetes alone. BMI ≥ 30 + prediabetes (A1C 5.7-6.4 or fasting glucose 100-125) creates a reasonable weight-loss PA. Pure prediabetes without obesity is not a viable pathway.
Insurance
How coverage works
BMI ≥ 30 is required for PA approval. A1C alone does not unlock weight-loss-indicated GLP-1s. Metformin remains first-line for prediabetes alone.
Cautions
Discontinuation often leads to weight regain and glucose normalization reversal. GLP-1 use in prediabetes is increasingly framed as chronic rather than time-limited therapy.
Editorial verdict
What we recommend
For BMI ≥ 30 patients with prediabetes, the diabetes-prevention case is well-evidenced. Frame the conversation with your prescriber around BMI + metabolic risk, not A1C alone. Plan for chronic use, not a short course.
Frequently asked questions
Which GLP-1 is best for prediabetes?+
Our #1 pick is Zepbound. It scored highest on effectiveness and safety for prediabetes based on our clinical rubric.
What does the evidence show for GLP-1 medications and prediabetes?+
STEP-1 follow-up data and Mounjaro Phase 2 prevention studies show 60-70% reduction in T2D incidence over 3 years in high-risk prediabetic patients. The effect persists after discontinuation in roughly half of patients, suggesting durable metabolic reset.
Does insurance cover GLP-1 medications for prediabetes?+
BMI ≥ 30 is required for PA approval. A1C alone does not unlock weight-loss-indicated GLP-1s. Metformin remains first-line for prediabetes alone.
Are GLP-1 medications safe for prediabetes?+
Discontinuation often leads to weight regain and glucose normalization reversal. GLP-1 use in prediabetes is increasingly framed as chronic rather than time-limited therapy.
The bottom line
Best GLP-1 for prediabetes
For BMI ≥ 30 patients with prediabetes, the diabetes-prevention case is well-evidenced. Frame the conversation with your prescriber around BMI + metabolic risk, not A1C alone. Plan for chronic use, not a short course.